Molnlycke Mepilex XT 15x15 cm 5s (211300)

Product Overview

Mepilex XT is an absorbent foam dressing engineered for moderately to highly exuding wounds where viscous exudate is present. The dressing combines a soft, conformable polyurethane foam pad with an inner channelled wound-contact layer bonded with Safetac, the original silicone adhesive technology. Channels in the contact layer transport viscous exudate into the absorbent core while preserving a moist wound environment consistent with TIME (Tissue, Infection/inflammation, Moisture, Edges) wound-bed preparation principles.

Safetac creates a soft seal at the periwound skin that minimises lateral spread of exudate, reducing the risk of maceration and skin stripping at dressing change. Clinical evaluations demonstrate atraumatic removal compared with conventional adhesives, supporting the WUWHS minimising-pain-at-dressing-change consensus and reducing patient-reported pain scores. The dressing is intended for use under graduated compression therapy in venous leg ulcer management when clinically indicated.

Specifications

Clinical Indications

• Pressure injuries (Stage II and beyond) with moderate to heavy exudate
• Venous leg ulcers and arterial leg ulcers under appropriate compression or off-loading
• Diabetic foot ulcers requiring conformable foam under contact-cast or off-loading
• Traumatic wounds including skin tears (ISTAP Type 1, 2 and 3)
• Secondary-healing post-surgical wounds and dehisced incisions
• Moderately exuding partial-thickness burns under physician supervision

Frequently Asked Questions

Why are exudate channels useful for viscous exudate?
Standard foam dressings rely on capillary uptake, which can stall when exudate is highly viscous (for example chronic venous ulcer or sloughy wound exudate). The channelled Safetac contact layer of Mepilex XT provides preferential pathways into the foam core, supporting the moisture-balance objective described in the WUWHS Wound Exudate principles document.

How is the 15 x 15 cm size selected versus 10 x 10 cm?
EWMA practice recommends a dressing margin of at least 1–2 cm beyond the wound edge onto intact periwound skin. The 15 x 15 cm presentation is suited to wounds of approximately 11 x 11 cm or smaller; for larger wounds use multiple dressings or a larger format.

Can the dressing be left in place under compression therapy?
Yes, Mepilex XT is designed for use under multilayer compression bandaging. Wear time is determined by clinical assessment of exudate strikethrough, periwound skin condition and infection signs, typically up to 7 days when not saturated.

How is the dressing supplied for Singapore healthcare buyers?
EMIS supplies Mepilex XT 211300 in original Mölnlycke cartons (5 dressings per carton). Product is intended for healthcare-professional use; bulk and institutional pricing for clinics, nursing homes and community-care providers in Singapore is available on request, with HSA-compliant import documentation.

Is Mepilex XT compatible with topical antimicrobials?
Mepilex XT is non-medicated; it is compatible with most topical antiseptics and antimicrobials commonly used in wound bed preparation. Where infection is confirmed or suspected, consider an antimicrobial primary layer (for example Mepilex Ag) consistent with IWII Wound Infection in Clinical Practice 2022 guidance.